{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:56Z","timestamp":1791704816187,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.102987","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:00:10Z","timestamp":1789416010000},"page":"102987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An immune related cell death index for prognostic stratification and immunotherapy response prediction in oral cancer"],"prefix":"10.1016","volume":"73","author":[{"family":"Jinglin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaochen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2178-2896","authenticated-orcid":false,"given":"Liangsicheng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102987_bib0001","first-page":"418","volume":"7","author":"McGuire","year":"2015"},{"issue":"6","key":"10.1016\/j.tranon.2026.102987_bib0002","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/diagnostics11061004","article-title":"Application and performance of artificial intelligence technology in oral cancer diagnosis and prediction of prognosis: a systematic review","volume":"11","author":"Khanagar","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.tranon.2026.102987_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.825266","article-title":"Oral potentially malignant disorders: etiology, pathogenesis, and transformation into oral cancer","volume":"13","author":"Kumari","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.tranon.2026.102987_bib0004","doi-asserted-by":"crossref","first-page":"8323","DOI":"10.3390\/ijms23158323","article-title":"Microbiota and oral cancer as a complex and dynamic microenvironment: a narrative review from etiology to prognosis","volume":"23","author":"Pignatelli","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.tranon.2026.102987_bib0005","first-page":"143","article-title":"Impact of oral cancer on quality of life","volume":"62","author":"Valdez","year":"2018","journal-title":"Dent. Clin."},{"issue":"5","key":"10.1016\/j.tranon.2026.102987_bib0006","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.oraloncology.2003.09.012","article-title":"Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention","volume":"40","author":"Hsu","year":"2004","journal-title":"Oral Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.102987_bib0007","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-0714.2008.00732.x","article-title":"Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines","volume":"38","author":"Hsiao","year":"2009","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.tranon.2026.102987_bib0008","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tox.2012.10.026","article-title":"The mechanism of carvacrol-evoked [Ca2+] i rises and non-Ca2+-triggered cell death in OC2 human oral cancer cells","volume":"303","author":"Liang","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.tranon.2026.102987_bib0009","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40291-018-0329-9","article-title":"Programmed cell death, from a cancer perspective: an overview","volume":"22","author":"Mishra","year":"2018","journal-title":"Mol. Diagn. Ther."},{"issue":"1001","key":"10.1016\/j.tranon.2026.102987_bib0010","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/pgmj.2008.072629","article-title":"Programmed cell death and cancer","volume":"85","author":"Sun","year":"2009","journal-title":"Postgrad. Med. J."},{"issue":"12","key":"10.1016\/j.tranon.2026.102987_bib0011","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"3","key":"10.1016\/j.tranon.2026.102987_bib0012","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/carcin\/21.3.485","article-title":"Apoptosis in cancer","volume":"21","author":"Lowe","year":"2000","journal-title":"Carcinogenesis"},{"issue":"12","key":"10.1016\/j.tranon.2026.102987_bib0013","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/nrc2254","article-title":"Role of autophagy in cancer","volume":"7","author":"Mathew","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102987_bib0014","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/cancers12010164","article-title":"Ferroptosis in cancer cell biology","volume":"12","author":"Bebber","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.tranon.2026.102987_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nri.2016.107","article-title":"Immunogenic cell death in cancer and infectious disease","volume":"17","author":"Galluzzi","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.tranon.2026.102987_bib0016","doi-asserted-by":"crossref","unstructured":"Li Z, Wang X, Tasich K, Hike D, Schumacher JG, Zhou Q, Man W, Huang Y: Eupatilin unveiled: an in-depth exploration of research advancements and clinical therapeutic prospects. 2025, 13(2):104\u2013117.","DOI":"10.1515\/jtim-2025-0016"},{"key":"10.1016\/j.tranon.2026.102987_bib0017","series-title":"Exon Publications","first-page":"195","article-title":"Engaging the lysosome and lysosome-dependent cell death in cancer","author":"Berg","year":"2022"},{"key":"10.1016\/j.tranon.2026.102987_bib0018","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fonc.2014.00302","article-title":"The mitochondrial permeability transition pore and cancer: molecular mechanisms involved in cell death","volume":"4","author":"Bonora","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tranon.2026.102987_bib0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy","volume":"18","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tranon.2026.102987_bib0020","series-title":"Seminars in Thrombosis and hemostasis:2014","first-page":"277","article-title":"NETosis: a new factor in tumor progression and cancer-associated thrombosis","author":"Demers","year":"2014"},{"key":"10.1016\/j.tranon.2026.102987_bib0021","doi-asserted-by":"crossref","unstructured":"Kashif AM, Ouyang Y, Li Y, Pan B: NETosis and pyroptosis of immune cells in sepsis. 2025, 13(4):318\u2013327.","DOI":"10.1515\/jtim-2025-0035"},{"key":"10.1016\/j.tranon.2026.102987_bib0022","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2016.01.003","article-title":"Paraptosis in the anti-cancer arsenal of natural products","volume":"162","author":"Lee","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.tranon.2026.102987_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109595","article-title":"Pyroptosis: a new frontier in cancer","volume":"121","author":"Fang","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.tranon.2026.102987_bib0024","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1158\/1078-0432.CCR-12-2647","article-title":"A 13-gene signature prognostic of HPV-negative OSCC: discovery and external validation","volume":"19","author":"Lohavanichbutr","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.tranon.2026.102987_bib0025","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1002\/ijc.29649","article-title":"The role of HPV RNA transcription, immune response-related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer","volume":"137","author":"Wichmann","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.tranon.2026.102987_bib0026","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41467-017-01460-0","article-title":"Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma","volume":"8","author":"Lauss","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.tranon.2026.102987_bib0027","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","article-title":"Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma","volume":"165","author":"Hugo","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.tranon.2026.102987_bib0028","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","article-title":"Tumor and microenvironment evolution during immunotherapy with nivolumab","volume":"171","author":"Riaz","year":"2017","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.tranon.2026.102987_bib0029","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-16-3556","article-title":"Immune-related gene expression profiling after PD-1 blockade in non\u2013small cell lung carcinoma, head and neck squamous cell carcinoma, and melanoma","volume":"77","author":"Prat","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.tranon.2026.102987_bib0030","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/s41467-023-36691-x","article-title":"Single-cell transcriptome profiling of the stepwise progression of head and neck cancer","volume":"14","author":"Choi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102987_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1460547","article-title":"Integrating multi-omics and machine learning survival frameworks to build a prognostic model based on immune function and cell death patterns in a lung adenocarcinoma cohort","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.tranon.2026.102987_bib0032","article-title":"ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.tranon.2026.102987_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.687975","article-title":"IOBR: multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures","volume":"12","author":"Zeng","year":"2021","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.tranon.2026.102987_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107468","article-title":"pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels","volume":"9","author":"Geeleher","year":"2014","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.tranon.2026.102987_bib0035","first-page":"1725","article-title":"Targeting PDK4 inhibits breast cancer metabolism","volume":"8","author":"Guda","year":"2018","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.tranon.2026.102987_bib0036","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2147\/CMAR.S185015","article-title":"Overexpression of PDK4 is associated with cell proliferation, drug resistance and poor prognosis in ovarian cancer","volume":"Volume 11","author":"Wang","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"9","key":"10.1016\/j.tranon.2026.102987_bib0037","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1158\/1535-7163.MCT-18-0063","article-title":"The role of pyruvate dehydrogenase kinase-4 (PDK4) in bladder cancer and chemoresistance","volume":"17","author":"Woolbright","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.tranon.2026.102987_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.102987_bib0039","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.102987_bib0040","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s10147-017-1161-7","article-title":"PD-L1 induced by IFN-\u03b3 from tumor-associated macrophages via the JAK\/STAT3 and PI3K\/AKT signaling pathways promoted progression of lung cancer","volume":"22","author":"Zhang","year":"2017","journal-title":"Int. J. Clin. Oncol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:32:27Z","timestamp":1791703947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S1936523326003232"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102987","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An immune related cell death index for prognostic stratification and immunotherapy response prediction in oral cancer","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102987"}}